<DOC>
	<DOC>NCT00594945</DOC>
	<brief_summary>Evaluate the safety and efficacy of intranasal Clonazepam in subjects with epilepsy.</brief_summary>
	<brief_title>Study of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures</brief_title>
	<detailed_description />
	<mesh_term>Seizures</mesh_term>
	<mesh_term>Epilepsy</mesh_term>
	<mesh_term>Clonazepam</mesh_term>
	<criteria>Diagnosis of refractory epilepsy No Nasal conditions that would preclude the use of intranasal product Subject with a clinical significant unstable medical abnormality Subject currently or regularly taking Clonazepam</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>